CClinicalTrials.gg
CompletedNCT05340959Updated Oct 3, 2023

Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

An observational study in Edentulous Alveolar Ridge, sponsored by University of Baghdad. Completed at 1 site in Iraq. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-03.

Sponsored by University of Baghdad · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
16
Ages
18 Years and older
Sex
All
01

Study summary

A prospective observational study guided by the guidelines of Strengthening The Reporting Of Observational Study in Epidemiology (STROBE) in 2014, that will be conducted to evaluate implant stability using three devices; Osstell®, Peiotest® and AnyCheck® and comparing the results.

Read the detailed description

In this study, 40 dental implants will be installed in osteotomy sites for patients with single or multiple missing tooth or teeth based on radiographic findings (CBCT).

The primary stability will be measured immediately after implant installation using three devices :

  1. Osstell : based on resonance frequency analysis (RFA).
  2. Periotest: based on damping effect.
  3. AnyCheck: based on tapping motion. Secondary stability will be measured after 12 weeks using the same devices mentioned above.
02

Conditions studied

  • Edentulous Alveolar Ridge

Browse trials for

03

In context

Mouth, Edentulous

244 studies on the registry are indexed under Mouth, Edentulous; 37 are open to participants now.

This study's enrollment of 16 is below the median of 39 across 52 observational studies indexed under Mouth, Edentulous.

Browse Mouth, Edentulous studies →

Lead sponsor

University of Baghdad is the lead sponsor of 164 studies on the registry; 66 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy adults with missing one or more tooth or teeth seeking for dental implant treatment.

Inclusion criteria

  1. Healthy patients over 18 years of either gender, having single or multiple missing teeth in the maxilla and/or mandible.
  2. Patient with adequate vertical bone height and width for implant placement based on preoperative radiographic findings (CBCT).
  3. Ability to tolerate conventional surgical and restorative procedures.
  4. Patients who are willing to comply with the study and give their consent.

Exclusion criteria

Exclusion Criteria:

  1. Active infection or inflammation in the implant zone.
  2. Presence of any uncontrolled systemic diseases.
  3. Patients with a history of radiotherapy to the head and neck.
  4. Any patient requires advanced and complicated surgical techniques such as sinus lift and bone graft.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
16 participants (actual)
Patient registry
No

Groups and cohorts

  • Adult patient with single or multiple missing tooth or teeth requiring dental implants

    Adult patient with single or multiple missing tooth or teeth requiring dental implants, 40 dental implants will be placed in osteotomy sites based on radiographic findings (CBCT), the primary stability will be measured immediately after implant installation and secondary stability will be measured after 12 weeks . Both primary and secondary stability will be measured by three devices: 1. Osstell®: based on Resonance Frequency Analysis (RFA). 2. Periotest®: based on damping effect. 3. AnyCheck®: based on tapping-motion.

    Device: Devices: Osstell®, Periotest® and AnyCheck®.

Interventions

  • DeviceDevices: Osstell®, Periotest® and AnyCheck®.

    1. Osstell®: is a device that measure implant stability and based on resonance frequency analysis (RFA). Due to stiffness in the interface between the implant surface and the bone smart peg will vibrates accordingly. the more dense bone the higher stability, the higher frequency and higher Implant Stability Quotient (ISQ) value which is from 1-100. 2. Periotest®: is a device used to assess osseointegration of dental implants, so it measure implant stability . it is based on damping effect of implant. Showing the measurement digitally on a scale from -8 (low mobility) to 50 (high mobility) PTV units. 3. AnyCheck®: this is an implant stability meter that measures the stiffness of alveolar bone-implant interface through a tapping motion. Showing the measurement on a scale from 30 (low stability) to 85 (high stability).

06

What researchers measure

Primary outcomes

  1. Implant stability measured by Osstell®.

    Implant stability will be measured by: Osstell® (RFA) that is measured by Implant Stability Quotient (ISQ) Value.

    Time frame: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  2. Implant stability measured by Periotest®.

    Implant stability will be measured by: Periotest® (damping effect) that is measured by Periotest Value (PTV).

    Time frame: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  3. Implant stability measured by AnyCheck®.

    Implant stability will be measured by: AnyCheck® (tapping-motion) that is measured by Initial Stability Test (IST) Value.

    Time frame: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

  4. Correlation between values obtained by the devices

    Correlation between values obtained by: 1. Osstell® (RFA): measured by Implant Stability Quotient (ISQ) Value. 2. Periotest® (damping effect): measured by Periotest Value (PTV). 3. AnyCheck® (tapping-motion): measured by Initial Stability Test (IST) Value.

    Time frame: Changes in implant stability from baseline value measured immediately after implant installation (primary stability) and after 12 weeks (secondary stability).

07

Study locations

1 site
  • College of Dentistry, University of Baghdad
    Baghdad, Medical City 1417, Iraq
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05340959
Lead sponsor
University of Baghdad
Responsible party
Alamin Yassin Dhahi (Postgraduate Student, University of Baghdad) — Principal investigator
First posted
Apr 22, 2022
Start date
Dec 15, 2021
Primary completion
Sep 1, 2022
Completion
Dec 1, 2022
Last update
Oct 3, 2023

Study contacts

Alamin Y. Dhahi, B.D.S
principal investigator · University of Baghdad

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion